VA: 8% of Americans develop PTSD in their lifetime

According to the U.S. Department of Veterans Affairs, approximately 7 or 8 out of 100 individuals, an estimated 7% or 8% of the population, will have PTSD at some point during their life.

Approximately 8 million adults have PTSD during a given year, according to the VA.

June 27 marks PTSD Awareness Day. In honor of this, Healio/Psychiatry collected the top research articles on PTSD for psychiatrists.

FDA grants Breakthrough Therapy Designation to TNX-102 SL for PTSD

Tonix Pharmaceuticals recently announced the FDA granted Breakthrough Therapy Designation to TNX-102 SL, a low-dose sublingual formulation of cyclobenzaprine, for PTSD. Read more

Transcendental Meditation reduces stress, trauma in male inmates

Transcendental Meditation, a stress reduction technique, significantly reduced trauma, depression, anxiety and other stress symptoms in male inmates, according to recent findings. Read more

Childhood bullying predicts depression, anxiety, PTSD in young adulthood

College students who experienced childhood bullying and victimization were more likely to report symptoms of depression, anxiety and PTSD, according to recent findings. Read more

Stellate ganglion block alleviates anxiety, depression for veterans with PTSD

Among veterans with post-traumatic stress disorder, treatment with a single stellate ganglion block could help alleviate anxiety, depression and psychological pain rapidly and for long-term use, according to results presented at the American Society for Anesthesiologists Annual Meeting. Read more

Study suggests link between violence, depression, PTSD

PTSD was common among women receiving mindfulness therapy for depression at an urban federally qualified health center, suggesting an association between trauma and residing in a disadvantaged neighborhood. Read more

D-cycloserine may improve CBT outcomes for anxiety, OCD, PTSD

Recent findings suggested short-term efficacy of D-cycloserine augmentation of cognitive behavioral therapy for anxiety, obsessive-compulsive disorder, PTSD and phobia disorders. Read more

VIDEO: Research shows link between genotype, TBI and PTSD among recently deployed US soldiers

TORONTO — In this video, Grant L. Iverson, PhD, of Harvard Medical School, discusses results from a longitudinal study that assessed associations between genetics, traumatic stress, mild traumatic brain injury and combat exposure among American soldiers returning from deployment in Afghanistan. Watch video

PTSD, psychotropic medication increase dementia risk

PTSD diagnosis was associated with increased risk for dementia among veterans, which varied with use of psychotropic medications. Read more

Researchers critique DSM-5 changes to PTSD, call for action

The 2013 DSM-5 definition of PTSD, which includes revisions to the DSM-IV definition, is not an improvement and has consequences for clinicians and patients, according to a recent editorial in JAMA Psychiatry. Read more

Quetiapine monotherapy effective for PTSD

Quetiapine monotherapy, an atypical antipsychotic approved for treatment of schizophrenia, bipolar disorder and bipolar depression, was effective for PTSD, according to recent findings. Read more